Treatment for Acute Gout
For an adult male presenting with acute gout, initiate treatment immediately with NSAIDs, corticosteroids, or colchicine within 24 hours of symptom onset, selecting the agent based on renal function, cardiovascular comorbidities, and gastrointestinal risk factors. 1, 2
First-Line Treatment Selection Algorithm
Step 1: Assess contraindications to guide drug selection
- If severe renal impairment (eGFR <30 mL/min), cardiovascular disease, heart failure, cirrhosis, active GI bleeding, or on anticoagulation: Use corticosteroids as first-line therapy 3, 2, 4
- If no major contraindications and symptom onset <36 hours: NSAIDs or colchicine are appropriate 1
- If symptom onset >36 hours: Avoid colchicine; use NSAIDs or corticosteroids 1, 5
Step 2: Select specific agent and dosing
NSAIDs (if no contraindications)
- Naproxen 500 mg twice daily or indomethacin 50 mg three times daily at full anti-inflammatory doses 2
- Continue until complete symptom resolution 1, 2
- Add proton pump inhibitor if GI risk factors present 2
- High-strength evidence shows NSAIDs reduce pain effectively in acute gout 1
Corticosteroids (preferred in patients with comorbidities)
- Oral prednisone 30-35 mg daily for 5 days (fixed-dose regimen) 3
- Alternative: Prednisone 0.5 mg/kg/day for 5-10 days, then stop abruptly OR give for 2-5 days then taper over 7-10 days 1, 3
- For monoarticular involvement of 1-2 large joints: Intra-articular corticosteroid injection (triamcinolone acetonide 40 mg for large joints, 20 mg for smaller joints) provides rapid relief with minimal systemic effects 3, 2
- For NPO patients or inability to take oral medications: Intramuscular triamcinolone acetonide 60 mg OR IV methylprednisolone 0.5-2.0 mg/kg 3, 4
- High-strength evidence (Level A) supports corticosteroids as equally effective as NSAIDs with fewer adverse effects 1, 3
Colchicine (only if started early)
- Must be initiated within 36 hours of symptom onset for optimal efficacy 1, 5
- Dosing: 1.2 mg (two tablets) at first sign of flare, followed by 0.6 mg (one tablet) one hour later 5
- Maximum dose: 1.8 mg over one hour period 5
- Do not repeat loading dose for at least 3 days 5
- Moderate-strength evidence shows low-dose colchicine is as effective as high-dose with fewer GI adverse events 1
- Adjust dose for drug interactions: If on strong CYP3A4 inhibitors (clarithromycin, ketoconazole, ritonavir), reduce to 0.6 mg × 1 dose, followed by 0.3 mg one hour later 5
Combination Therapy for Severe Attacks
For severe pain, polyarticular involvement, or inadequate response to monotherapy:
- Combine oral corticosteroids + colchicine 1, 2, 4
- Combine intra-articular corticosteroids + any oral modality 1, 2
- Never combine NSAIDs with systemic corticosteroids due to synergistic GI toxicity 2, 4
- Inadequate response defined as <20% pain improvement within 24 hours OR <50% improvement at ≥24 hours 1, 3
Critical Management Principles
- Initiate treatment within 24 hours of symptom onset for optimal outcomes—earlier treatment yields better response regardless of agent 1, 2
- Do NOT interrupt ongoing urate-lowering therapy during an acute attack 1, 2, 4
- Do NOT initiate urate-lowering therapy during the acute attack 2
- Continue anti-inflammatory treatment until complete symptom resolution 1, 2
Common Pitfalls to Avoid
- Avoid NSAIDs in renal impairment (eGFR <30), heart failure, cirrhosis, active GI bleeding, recent MI, or anticoagulation 2, 4
- Avoid colchicine if symptom onset >36 hours ago—efficacy is lost 1, 5
- Avoid high-dose colchicine—no additional benefit and significantly more GI adverse events 1
- Avoid starting colchicine in patients already on prophylactic colchicine—choose alternative therapy instead 1
- Screen for corticosteroid contraindications: active systemic fungal infections, uncontrolled diabetes, active peptic ulcer disease 3, 4
Special Populations
Renal impairment (eGFR <30 mL/min):
- Corticosteroids are the safest first-line option with no dose adjustment required 3, 4
- NSAIDs can cause acute kidney injury 3
- Colchicine carries fatal toxicity risk in severe renal impairment 3
Patients on anticoagulation:
- Corticosteroids are the safest choice 4
- Never use NSAIDs due to unacceptable bleeding risk 4
- Colchicine can be used with caution and dose adjustment for drug interactions 4
Cardiovascular disease or heart failure: